FUSN 21.55 (+0%)
CA36118A1003BiotechnologyBiotechnology

Fusion Pharmaceuticals (FUSN) Financial Metrics

This table shows a selected set of financial data points of Fusion Pharmaceuticals (FUSN). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 0 0 0 0 -0.38 2.07M -85.69M -87.6M -94.9M 61.46M
2022 -2 0 -1.57 137.81M -0.37 1.46M -75.42M -86.74M -87.61M 43.86M
2021 -1.9 0 -2.19 177.64M -0.29 1.44M -77.23M -80.53M -81.05M 52.9M
2020 -3.56 0 -3.31 258.89M -0.41 0 -30.89M -31.05M -78.33M 90.52M
2019 -0.76 0 0 0 -0.32 0 -14.15M -17.75M -16.19M 65.34M
2018 -0.62 0 0 0 -0.74 0 -10.99M -11.36M -11.65M 28.77M
2017 -0.34 0 0 0 0 0 -6.22M -6.24M -6.26M 0

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.